Picture of Dr Reddy's Laboratories logo

RDY Dr Reddy's Laboratories Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

Annual cashflow statement for Dr Reddy's Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

2021
March 31st
2022
March 31st
2023
March 31st
2024
March 31st
2025
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
IAS
IAS
IAS
IAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line28,83530,61460,48572,01076,795
Depreciation
Non-Cash Items8,5847,1024,457-1,0482,578
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-14,004-21,260-18,569-40,229-49,982
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities35,70328,10858,87545,43346,428
Capital Expenditures-12,561-19,049-18,866-27,435-34,398
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-10,099-7,338-22,507-12,848-16,623
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities-22,660-26,387-41,373-40,283-51,021
Financing Cash Flow Items-1,321-1,345-1,853-2,266-3,483
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-298-2,422-26,861-3,76311,855
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash12,85832-9,0731,3287,486